Recent Articles

Daily cup of coffee may prevent afib recurrence

Gene-editing therapy lowers harmful blood fats in early study

What is EMDR therapy, and who can it help?

GLP-1 drugs versus bariatric surgery for treating obesity

Trying to lose weight? Be careful not to lose muscle

Two dumbbells, three exercises, and 10 minutes

Easing the emotional burden of IBS

Modify your push-ups to meet your fitness level

What is long QT syndrome?

Stroke survivors may benefit from very low LDL levels

Dawn Sugarman, PhD

Contributor

Dawn E. Sugarman, PhD, is an assistant professor in the department of psychiatry at Harvard Medical School, and a research psychologist at McLean Hospital in the division of alcohol, drugs, and addiction. Dr. Sugarman received her PhD from Syracuse University, and completed predoctoral and postdoctoral fellowships at Yale School of Medicine. Her research primarily focuses on the use of technology in increasing access to evidence-based treatments for substance use disorders, with an emphasis on special populations such as women and individuals with substance use and other co-occurring psychiatric disorders.

Dr. Sugarman was the inaugural recipient of the Sarles Young Investigator Award for Research on Women and Addiction at McLean Hospital. She is the current recipient of a National Institute on Drug Abuse–funded career development award focused on increasing women’s engagement in medication treatment for opioid use disorder through digital intervention. Dr. Sugarman also serves as the communications editor for the Harvard Review of Psychiatry.

Posts by Dawn Sugarman, PhD

Staying Healthy

Rising alcohol use among older adults

Women's Health

Women, alcohol, and COVID-19

Result 1 - 2 of 2